The independent source for health policy research, polling, and news.
January 18, 2024
In this column, KFF’s President and CEO Drew Altman explores the nation’s twin health cost crises of affordability, especially for people who are sick and need a lot of health care, and national health spending, and why the solutions often work at cross purposes.
Beyond the Data Read PostJanuary 4, 2024
In his latest column, President and CEO Drew Altman discusses a recent Congressional Budget Office (CBO) estimate that the Centers for Medicare and Medicaid Innovation (CMMI)’s payment and delivery demonstrations have cost Medicare money, and what it means for the future of value-based payment.
Beyond the Data Read PostDecember 12, 2023
In this column, KFF President and CEO Drew Altman examines the threat posed by health misinformation and opportunities to combat it by relying on the messengers the public trusts most for health information, which includes doctors and local television news sources.
Beyond the Data Read PostNovember 28, 2023
In his Beyond the Data column, KFF President and CEO Drew Altman discusses how how family health coverage is no longer affordable for workers at small employers, contributing to the health cost crisis affecting the American people.
Beyond the Data Read PostOctober 26, 2023
In this JAMA Health Forum column, KFF’s Drew Altman and Larry Levitt examine how the complexity of the health care system – with all of its red tape – can be as big a problem for patients as the traditional big three problems of costs, quality and access.
Column Read PostSeptember 6, 2023
As the Biden administration begins the process of negotiation drug prices for Medicare as authorized in the Inflation Reduction Act, KFF’s Larry Levitt probes some of the arguments against it and the policy and political implications of the debate in this New York Times op-ed column.
Op-Ed Read Post